EBS

Emergent Biosolutions Stock Analysis

AI Rating

Good
  • Quality2/10
  • Growth↑ 8/10
  • Value↓ 4/10
Emergent Biosolutions sales and earnings growth
EBS Growth
Good
  • Revenue Y/Y↓ -26.42%
  • EPS Y/Y↑ 94.49%
  • FCF Y/Y↓ -3.49%
Emergent Biosolutions gross and profit margin trends
EBS Profitability
Fair
  • Gross margin ↑ 54.20%
  • EPS margin↓ -1.30%
  • ROIC 5Y↓ -11.68%
Emergent Biosolutions net debt vs free cash flow
EBS Risk
Good
  • Debt / Equity↓ 1.1
  • Debt / FCF↓ 3.0
  • Interest coverage↓ 1.1

Emergent Biosolutions stock volatility is higher than the overall market. We give it a Good risk rating.

↗ More Drug Manufacturers - Specialty & Generic stocks